Altman Z Score
-20.27
+0.02+0.10%
Fri, 29 Nov 2024 14:30:00 GMT
Summary:
COSCIENS Biopharma altman Z score is currently -20.27, with a rise of +0.02 (+0.10%) during the most recent trading day. Over the past year, it has dropped by -5.52 (-37.42%).CSCI Altman Z Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI Altman Z Score Performance
| PeriodPeriod | Altman Z scoreAltman Z score | PricePrice | Market capMarket cap |
|---|---|---|---|
| todaytoday | +0.1% | +1.3% | +1.3% |
| 1 m1 month | -1.7% | -13.3% | -13.3% |
| 3 m3 months | -2.2% | -16.8% | -16.6% |
| 6 m6 months | -11.2% | -69.5% | -48.4% |
| ytdytd | -4.6% | -57.9% | -28.9% |
| 1 y1 year | -37.4% | -60.7% | -33.5% |
| 5 y5 years | -147.0% | -96.5% | -94.0% |
COSCIENS Biopharma Altman Z Score History
| Date | Value |
|---|---|
| 2024 | -20.27(+4.6%) |
| 2023 | -19.38(+44.2%) |
| 2022 | -13.44(+745.3%) |
| 2021 | -1.59(-74.8%) |
| 2020 | -6.30(-247.5%) |
| 2019 | 4.27(-97.7%) |
| 2018 | 186.56(+390.4%) |
| 2017 | 38.04(-63.4%) |
| 2016 | 103.99(+235.5%) |
| 2015 | 31.00(-97.0%) |
| 2014 | 1024.18(-59.3%) |
| 2013 | 2517.00(-50.9%) |
| Date | Value |
|---|---|
| 2012 | 5130.33(-76.6%) |
| 2011 | 21.97 K(-4.7%) |
| 2010 | 23.04 K(+158.6%) |
| 2009 | 8910.15(+99.7%) |
| 2008 | 4462.04(-77.8%) |
| 2007 | 20.07 K(-76.5%) |
| 2006 | 85.52 K(-10.3%) |
| 2005 | 95.38 K(-34.2%) |
| 2004 | 144.92 K(-0.5%) |
| 2003 | 145.69 K(+17.8%) |
| 2002 | 123.66 K(-21.3%) |
| 2001 | 157.17 K(+111.4%) |
| 2000 | 74.36 K |
FAQ
- What is COSCIENS Biopharma altman Z score?
- What is CSCI altman Z score year-to-date change?
- What is COSCIENS Biopharma altman Z score year-on-year change?
What is COSCIENS Biopharma altman Z score?
The current altman Z score of CSCI is -20.27
What is CSCI altman Z score year-to-date change?
COSCIENS Biopharma altman Z score has changed by -0.89 (-4.59%) since the beginning of the year
What is COSCIENS Biopharma altman Z score year-on-year change?
Over the past year, CSCI altman Z score has changed by -5.52 (-37.42%)